(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-yn-1-one

Catalog No. :
ACUAML271
CAS No. :
1970122-88-3
Molecular Formula :
C25H22N6O2
Molecular Weight :
438.49

IUPAC Name:(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-yn-1-one

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-yn-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-yn-1-one
IUPAC Name(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-yn-1-one
Molecular FormulaC25H22N6O2
Molecular Weight438.49
SMILESC#CC(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1
InChI KeyNAQYQSPFDLXJIK-GOSISDBHSA-N
Synonym2-Propyn-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-;l-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-lHpyrazolo [3,4-d]pyrimidin-l-yl]-l-piperidinyl]-2-propyn-l-one;IBT6A-CO-ethyne
CAS No.1970122-88-3

Synthetic Route by SureRoute

1. ACUAML271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBJDO743 route compound structure diagram
    ACBJDO7431022150-12-4 In Stock
  4. Then
  5. ACUAML271 route product structure diagram
    ACUAML2711970122-88-3
Inquiry

2. ACUAML271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHOZW985 route compound structure diagram
    ACHOZW985269410-26-6 In Stock
  4. Then
  5. ACUAML271 route product structure diagram
    ACUAML2711970122-88-3
Inquiry

Comments (0)